Drug-eluting Stent Market Scope and Size by 2031
The Drug-eluting Stent Market is expected to register a CAGR of 5.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product Type [Polymer-Based Coatings (Non-biodegradable Polymers and Biodegradable Polymers) and Polymer-Free Coatings (Micro porous Surface, Micro structured Surface, Slotted Tubular Surface, and Nanoporous Surface)], Application (Coronary Artery Disease and Peripheral Artery Disease), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
Purpose of the ReportThe report Drug-eluting Stent Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Drug-eluting Stent Market Segmentation
Product Type [Polymer-Based Coatings- Non-biodegradable Polymers and Biodegradable Polymers and Polymer-Free Coatings
- Coronary Artery Disease and Peripheral Artery Disease
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
Strategic Insights
Drug-eluting Stent Market Growth Drivers- Rising Cases of Cardiovascular Diseases: The prime driver for the drug-eluting stent market is advancement in cardiovascular diseases. In fact, conditions such as coronary artery disease are increasingly becoming more common, thus fueling a requirement for effective treatments. Drug-eluting stents are increasingly preferred by clinicians when complicated cardiovascular conditions exist primarily for their increased efficacy in the prevention of restenosis and improved patient outcomes.
- Advancements in Stent Technology: Technological advancements in stents are, therefore an important driver for the growth of the market of drug-eluting stents. Further advancement in design, materials, and mechanisms of drug delivery enhance higher safety and efficacy with fewer complications compared to conventional systems. Better performance of these advanced interventional cardiology solutions further drives this market of drug-eluting stents as clinicians adopt them.
- Growing Awareness of Treatment Options: Growth in awareness among patients and medical professionals about the therapeutic options available is the primary driver for the drug-eluting stent market. Better education with sufficient availability of information has led to an overall understanding of the benefits and risks involved in the use of drug-eluting stents. Such awareness leads to informed decisions, which in turn further boost the device acceptance rate and increase the growth rate of the market with high patient rates for advanced cardiovascular treatments emerging in the future.
- Shift Towards Individualized Medicine: One of the notable strides in the overall drug-eluting stents market is the ongoing shift towards, and emphasis on, personalized medicine. Improving treatment outcomes through enhanced stent selection and specific drug formulations based on unique patient traits. As the benefits of genetic profiling and any other patient related aspects continue to gain popularity, the focus of manufacturers has shifted towards the production of drug eluting stents which are tailored to certain heart conditions in a bid to enhance patients’ outcome satisfaction.
- Introduction to Bioresorbable Stents: The introduction of bioresorbable stent systems is affecting the drug eluting stents market as a whole. These products are unique in that where they are implanted, they will slowly be absorbed over time and thus, the issues of permanently residing implants will be mitigated. As clinical data supports their use, physicians are more frequently turning to bioresorbable devices for patients, heralding the emergence of a new market allowing temporary implantation of vascular devices.
- Incorporation of State of the Art Imaging Techniques: The use of imaging systems in drug eluting technologies is yet another emerging trend. Intra-vascular sonography or optical coherence tomography improves the procedural guidance, enabling a better position of the stent and also evaluation of the conditions of the vessels. This trend not only helps in the improvement of procedural results but also encourages the production of stents that can be used with such advanced imaging systems, which helps in the growth of the market.
- Expansion into Emerging Markets: The drug-eluting stent market has an unfilled space when looking at the opportunity for growth in the emerging regions of the world. With improvement in healthcare system and more people accessing advanced treatments for cardiovascular diseases, the market for drug-eluting stents is likely to rise. Expansion to such regions by companies with a strategic plan will ensure that the growing patient base is well served, improving the company’s operations in those areas and the cardiovascular treatment in such regions.
- Collaboration with Healthcare Providers: Developing relationship with payers and other third parties is an additional worthy aspect in drug eluting stent market. Manufacturers can initiate clinical studies and obtain actual device use data through collaboration with hospitals and cardiovascular centers. These relationships add value to the product and help them gain sufficient acceptance of the drug eluting stent which accelerates growth and at the same time enhances the treatment protocols and results.
- Focus on Innovative Drug Formulations: Exploration of new drug delivery platforms such as drug coating onto stents is an opportunity that cannot be overlooked. Investigating better forms of antiproliferative and anti-inflammatory compounds will yield better results for the stent and lower side effects. Distinctive products that meet the current expectations of the clinicians and patients while increasing the efficacy of the treatment can be manufactured by improving existing drug-eluting technologies.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Drug-eluting Stent Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Drug-eluting Stent Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the drug-eluting stent market in 2023
The market drivers include rising cases of cardiovascular diseases and advancements in stent technology are driving the drug-eluting stent market
Introduction to bioresorbable stents are likely to remain the key trend during the forecast period
The drug-eluting stent market majorly consists of the players such as Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation among others.
Asia Pacific region is likely to witness fastest growth rate during the forecast period.
The drug-eluting stent market is estimated to grow with a CAGR of 5.4% from 2023 to 2031.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug-eluting Stent Market - By Product Type
1.3.2 Drug-eluting Stent Market - By Region
1.3.2.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. DRUG-ELUTING STENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG-ELUTING STENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DRUG-ELUTING STENT MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG-ELUTING STENT - GLOBAL MARKET OVERVIEW
6.2. DRUG-ELUTING STENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG-ELUTING STENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. POLYMER-BASED COATINGS AND POLYMER-FREE COATINGS
7.3.1. Overview
7.3.2. Polymer-Based Coatings and Polymer-Free Coatings Market Forecast and Analysis
8. DRUG-ELUTING STENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Drug-eluting Stent Market Overview
8.1.2 North America Drug-eluting Stent Market Forecasts and Analysis
8.1.3 North America Drug-eluting Stent Market Forecasts and Analysis - By Product Type
8.1.4 North America Drug-eluting Stent Market Forecasts and Analysis - By Countries
8.1.4.1 United States Drug-eluting Stent Market
8.1.4.1.1 United States Drug-eluting Stent Market by Product Type
8.1.4.2 Canada Drug-eluting Stent Market
8.1.4.2.1 Canada Drug-eluting Stent Market by Product Type
8.1.4.3 Mexico Drug-eluting Stent Market
8.1.4.3.1 Mexico Drug-eluting Stent Market by Product Type
8.1.4.4 US Drug-eluting Stent Market
8.1.4.4.1 US Drug-eluting Stent Market by Product Type
8.2. EUROPE
8.2.1 Europe Drug-eluting Stent Market Overview
8.2.2 Europe Drug-eluting Stent Market Forecasts and Analysis
8.2.3 Europe Drug-eluting Stent Market Forecasts and Analysis - By Product Type
8.2.4 Europe Drug-eluting Stent Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Drug-eluting Stent Market
8.2.4.1.1 Germany Drug-eluting Stent Market by Product Type
8.2.4.2 France Drug-eluting Stent Market
8.2.4.2.1 France Drug-eluting Stent Market by Product Type
8.2.4.3 Italy Drug-eluting Stent Market
8.2.4.3.1 Italy Drug-eluting Stent Market by Product Type
8.2.4.4 Spain Drug-eluting Stent Market
8.2.4.4.1 Spain Drug-eluting Stent Market by Product Type
8.2.4.5 United Kingdom Drug-eluting Stent Market
8.2.4.5.1 United Kingdom Drug-eluting Stent Market by Product Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Drug-eluting Stent Market Overview
8.3.2 Asia-Pacific Drug-eluting Stent Market Forecasts and Analysis
8.3.3 Asia-Pacific Drug-eluting Stent Market Forecasts and Analysis - By Product Type
8.3.4 Asia-Pacific Drug-eluting Stent Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Drug-eluting Stent Market
8.3.4.1.1 Australia Drug-eluting Stent Market by Product Type
8.3.4.2 China Drug-eluting Stent Market
8.3.4.2.1 China Drug-eluting Stent Market by Product Type
8.3.4.3 India Drug-eluting Stent Market
8.3.4.3.1 India Drug-eluting Stent Market by Product Type
8.3.4.4 Japan Drug-eluting Stent Market
8.3.4.4.1 Japan Drug-eluting Stent Market by Product Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Drug-eluting Stent Market Overview
8.4.2 Middle East and Africa Drug-eluting Stent Market Forecasts and Analysis
8.4.3 Middle East and Africa Drug-eluting Stent Market Forecasts and Analysis - By Product Type
8.4.4 Middle East and Africa Drug-eluting Stent Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Drug-eluting Stent Market
8.4.4.1.1 South Africa Drug-eluting Stent Market by Product Type
8.4.4.2 Saudi Arabia Drug-eluting Stent Market
8.4.4.2.1 Saudi Arabia Drug-eluting Stent Market by Product Type
8.4.4.3 U.A.E Drug-eluting Stent Market
8.4.4.3.1 U.A.E Drug-eluting Stent Market by Product Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Drug-eluting Stent Market Overview
8.5.2 South and Central America Drug-eluting Stent Market Forecasts and Analysis
8.5.3 South and Central America Drug-eluting Stent Market Forecasts and Analysis - By Product Type
8.5.4 South and Central America Drug-eluting Stent Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Drug-eluting Stent Market
8.5.4.1.1 Brazil Drug-eluting Stent Market by Product Type
8.5.4.2 Argentina Drug-eluting Stent Market
8.5.4.2.1 Argentina Drug-eluting Stent Market by Product Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. DRUG-ELUTING STENT MARKET, KEY COMPANY PROFILES
10.1. BOSTON SCIENTIFIC CORPORATION
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. MEDTRONIC, INC
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. ABBOTT LABORATORIES
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. BIOSENSORS INTERNATIONAL GROUP
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. BIOTRONIK
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. LEPU MEDICAL TECHNOLOGY
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. TERUMO MEDICAL CORPORATION
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. COOK MEDICAL
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SHANDONG JW MEDICAL SYSTEMS
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. STENTYS
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
- Boston Scientific Corporation
- Medtronic, Inc
- Abbott Laboratories
- Biosensors International Group
- Biotronik
- Lepu Medical Technology
- Terumo Medical Corporation
- Cook Medical
- Shandong JW Medical Systems
- Stentys
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.